Richard Pazdur has requested retirement, marking the end of his career at the U.S. Food and Drug Administration. Emily Hilliard, spokesperson for the U.S. Department of Health and Human Services (HHS), confirmed the news, stating:
“We respect Dr. Pazdur’s decision to retire and honor his 26 years of distinguished service at the FDA”.
Throughout his tenure, Dr. Pazdur served as Director of the FDA’s Oncology Center of Excellence (OCE) and previously as Director of the Office of Hematology and Oncology Products.